Tamoxifen Active Not Recruiting Phase 3 Trials for Stage IIA Breast Cancer / Cancer, Breast / Stage IIIA Breast Cancer / Recurrent Breast Carcinoma / Stage IB Breast Cancer / Stage IIB Breast Cancer / Stage IA Breast Cancer / Progesterone Receptor Positive Tumor / Estrogen Receptor Positive Breast Cancer Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00066690Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
NCT00066703Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
NCT00072462Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ
NCT00003857Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
NCT00541086Study of Anastrozole, Letrozole, or Exemestane With or Without Tamoxifen in Treating Postmenopausal Women With Hormone-Responsive Breast Cancer That Has Been Completely Removed By Surgery
NCT00412022HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer.